Literature DB >> 15935897

Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.

Cinzia Anna Ventura1, Ignazio Giannone, Donatella Paolino, Venerando Pistarà, Antonino Corsaro, Giovanni Puglisi.   

Abstract

The ability of 2,6-di-O-methyl-beta-cyclodextrin (DM-beta-Cyd) to include the anti-inflammatory drug celecoxib (CCB) was evaluated. The complex was prepared by kneading and freeze-drying methods and was characterized in the solid state and in aqueous solution. Water solubility and dissolution rate of CCB, in a medium simulating gastric fluid, significantly increased after complexation, with complete dissolution obtained after 30 and 180 min for the freeze-dried and kneaded complexes respectively. Phase solubility studies showed Ap-type diagrams. Stability constants for the 1:1 and 1:2 CCB-DM-beta-Cyd complexes and (1)H-NMR studies suggested a probable 1:1 inclusion complex and only an external interaction for the second Cyd molecule. Thermodynamic parameters of the binding process showed the existence of van der Waals forces between CCB and DM-beta-Cyd. DM-beta-Cyd influenced the permeation of CCB through the CaCo-2 cells monolayer. The increase of permeation observed was due to the fast dissolution rate of the included drug and to a destabilizing action exerted by the macrocycle on the biomembrane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935897     DOI: 10.1016/j.ejmech.2005.03.001

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  15 in total

1.  Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-β-cyclodextrin complexes.

Authors:  Jadel M Kratz; Marina R Teixeira; Karine Ferronato; Helder F Teixeira; Letícia S Koester; Cláudia M O Simões
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

2.  In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer.

Authors:  Yara Peluso Cid; Vinícius Pedrazzi; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

3.  Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.

Authors:  Angela Lopedota; Annalisa Cutrignelli; Valentino Laquintana; Nunzio Denora; Rosa Maria Iacobazzi; Mara Perrone; Elisabetta Fanizza; Maria Mastrodonato; Donatella Mentino; Antonio Lopalco; Nicoletta Depalo; Massimo Franco
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

4.  Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.

Authors:  Ana Figueiras; J M G Sarraguça; Rui A Carvalho; A A C C Pais; Francisco J B Veiga
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

5.  Interaction of liposome-encapsulated cisplatin with biomolecules.

Authors:  Bharat Baruah; Alexandr Surin
Journal:  J Biol Inorg Chem       Date:  2012-06-07       Impact factor: 3.358

6.  The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins.

Authors:  Ana Figueiras; Jorge M G Sarraguça; Alberto A C C Pais; Rui A Carvalho; J Francisco Veiga
Journal:  AAPS PharmSciTech       Date:  2010-02-05       Impact factor: 3.246

7.  Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation.

Authors:  M Yasmin Begum; Riyaz Ali M Osmani; Ali Alqahtani; Mohammed Ghazwani; Umme Hani; Hissana Ather; Akhtar Atiya; Mohamed Rahamathulla; Ayesha Siddiqua
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.752

8.  Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.

Authors:  Yi Lu; Tao Guo; Jianping Qi; Jiwen Zhang; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2012-09-12       Impact factor: 3.246

9.  Temperature Dependence of the Complexation Mechanism of Celecoxib and Hydroxyl-β-cyclodextrin in Aqueous Solution.

Authors:  Po-Chiang Chiang; Yue Shi; Yong Cui
Journal:  Pharmaceutics       Date:  2014-08-13       Impact factor: 6.321

Review 10.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.